[go: up one dir, main page]

ES530202A0 - Procedimiento para la preparacion de la hormona polipeptidica factor de crecimiento de nervios de humano. - Google Patents

Procedimiento para la preparacion de la hormona polipeptidica factor de crecimiento de nervios de humano.

Info

Publication number
ES530202A0
ES530202A0 ES530202A ES530202A ES530202A0 ES 530202 A0 ES530202 A0 ES 530202A0 ES 530202 A ES530202 A ES 530202A ES 530202 A ES530202 A ES 530202A ES 530202 A0 ES530202 A0 ES 530202A0
Authority
ES
Spain
Prior art keywords
polypeptidic
nerve growth
procedure
preparation
human nerve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES530202A
Other languages
English (en)
Other versions
ES8600783A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23873671&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES530202(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ES8600783A1 publication Critical patent/ES8600783A1/es
Publication of ES530202A0 publication Critical patent/ES530202A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/48Nerve growth factor [NGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES530202A 1983-03-03 1984-03-01 Procedimiento para la preparacion de la hormona polipeptidica factor de crecimiento de nervios de humano. Granted ES530202A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47196283A 1983-03-03 1983-03-03

Publications (2)

Publication Number Publication Date
ES8600783A1 ES8600783A1 (es) 1985-11-01
ES530202A0 true ES530202A0 (es) 1985-11-01

Family

ID=23873671

Family Applications (1)

Application Number Title Priority Date Filing Date
ES530202A Granted ES530202A0 (es) 1983-03-03 1984-03-01 Procedimiento para la preparacion de la hormona polipeptidica factor de crecimiento de nervios de humano.

Country Status (12)

Country Link
EP (1) EP0121338B2 (es)
JP (4) JPS6084299A (es)
KR (1) KR840008026A (es)
AT (1) ATE45382T1 (es)
AU (1) AU574350B2 (es)
CA (1) CA1220736A (es)
DE (1) DE3479321D1 (es)
DK (1) DK161152C (es)
ES (1) ES530202A0 (es)
IE (1) IE57013B1 (es)
NZ (1) NZ207337A (es)
ZA (1) ZA841597B (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3689845T3 (de) * 1985-09-12 2001-11-15 Scios Inc., Sunnyvale Rekombinanter fibroblast-wachstumsfaktor.
JPH01102096A (ja) * 1987-10-15 1989-04-19 Sanwa Kagaku Kenkyusho Co Ltd モチリン様活性を有するポリペプチド、その発現用微生物及び該ポリペプチドの製法
JPH01211490A (ja) * 1988-02-19 1989-08-24 Tosoh Corp ヒト神経成長因子遺伝子セグメント
IT1219874B (it) * 1988-03-18 1990-05-24 Fidia Farmaceutici Utilizzazione del fattore di crescita nervoso umano e sue composizioni farmaceutiche
US5134121A (en) * 1988-03-28 1992-07-28 Regents Of The University Of California Nerve growth factor peptides
US5683894A (en) * 1988-04-29 1997-11-04 University Of California Recombinant nerve growth factor
JPH0771509B2 (ja) * 1988-07-12 1995-08-02 工業技術院長 ヒトβ−NGFの発現法
US5082774A (en) * 1988-08-30 1992-01-21 The General Hospital Corporation Recombinant human nerve growth factor
US5272063A (en) * 1988-11-22 1993-12-21 Syntex (U.S.A.) Inc. Process of making human nerve growth factor
US6709837B1 (en) 1989-03-10 2004-03-23 Takeda Chemical Industries, Inc. Polypeptide and production thereof
SE8901715L (sv) * 1989-05-12 1990-11-13 Lope Medicine Ab En plasmid dna-konstruktion innehaallande dna-sekvenser
IT1232157B (it) * 1989-07-20 1992-01-25 Fidia Farmaceutici Purificazione del fattore di crescita nervoso tramite cromatografia a scambio di subunita'
ATE119938T1 (de) * 1989-08-21 1995-04-15 Takeda Chemical Industries Ltd Produktion von menschlichen nervenwachstumsfaktoren.
US5656435A (en) * 1989-08-28 1997-08-12 Takeda Chemical Industries, Ltd. Antibodies to peptides having NGF-like activity, said antibodies having no substantial cross-reactivity with NGF, and use thereof
GR1000980B (el) 1989-08-30 1993-03-31 Max Planck Gesellschaft Νευροτροφινη-3,ενας νεος neυροτροφικος παραγοντας που σχετιζεται με τον παραγοντα αναπτυξης νευρων και τον νευροτροφικο παραγοντα που προερχεται απο τον εγκεφαλο.
US5180820A (en) * 1989-08-30 1993-01-19 Barde Yves Alain Brain-derived neurotrophic factor
US6933276B1 (en) 1989-08-30 2005-08-23 Regeneron Pharmaceuticals, Inc. Methods of treating peripheral neuropathies using neurotrophin-3
IT1238348B (it) * 1989-11-16 1993-07-13 Processo per la preparazione di costrutti genetici per l'espressione del fattore di crescita nervoso in cellule eucariote.
JPH03244385A (ja) * 1990-02-21 1991-10-31 Hitachi Ltd ヒト神経成長因子の遺伝子工学的生産方法
IT1239271B (it) * 1990-02-27 1993-10-01 Fidia Spa Processo per l'espressione del fattore di crescita nervoso umano in cellule di artropoda frugiperda via infezione con baculovirus ricombinante
US5986070A (en) * 1990-04-06 1999-11-16 Amgen Inc. Production of biologically active NGF proteins
US5235043A (en) * 1990-04-06 1993-08-10 Synergen, Inc. Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
US5606031A (en) * 1990-04-06 1997-02-25 Lile; Jack Production and purification of biologically active recombinant neurotrophic protein in bacteria
US5389529A (en) * 1991-06-12 1995-02-14 Regeneron Pharmaceuticals, Inc. Modified lamβ signal sequence and processes for producing recombinant neurotrophins
NZ243084A (en) * 1991-06-12 1995-08-28 Regeneron Pharma Production and recovery of recombinant neurotrophins, genes for a modified lamb signal sequence, fusion genes and plasmids
DE4139000A1 (de) 1991-11-27 1993-06-03 Boehringer Mannheim Gmbh Verfahren zur gentechnologischen herstellung von biologisch aktivem ss-ngf
US6063757A (en) * 1995-11-29 2000-05-16 Urso; Richard G. Wound treatment method with nerve growth factor
WO1998011216A1 (fr) * 1996-09-11 1998-03-19 Sumitomo Pharmaceuticals Company, Limited Nouveau gene de semaphorine: semaphorine y
US6005081A (en) 1996-11-15 1999-12-21 Genentech, Inc. Purification of recombinant human neurotrophins
JP2001521375A (ja) * 1997-02-06 2001-11-06 アベンティス・ファーマスーティカルズ・インコーポレイテッド ヒト神経成長因子エクソン1およびエクソン3プロモーター
US6197551B1 (en) * 1998-01-27 2001-03-06 Millennium Pharmaceuticals, Inc. Spoil-1 protein and nucleic acid molecules and uses therefor
ITRM20050045A1 (it) * 2005-02-02 2006-08-03 Consiglio Nazionale Ricerche Proteina isolata da eisenia foetida simile all'ngf umano e usi relativi.
US7378359B2 (en) 2005-09-27 2008-05-27 Eleazer Howell B Moldable fibrous construction incorporating non-woven layers
US7294384B2 (en) 2005-09-27 2007-11-13 Milliken & Company Moldable construction incorporating bonding interface
US7300691B2 (en) 2005-09-27 2007-11-27 Milliken & Company Moldable construction incorporating non-olefin bonding interface
US20080124513A1 (en) 2006-09-11 2008-05-29 Eleazer Howell B Moldable fabric with unidirectional tape yarns
JP6767688B2 (ja) 2015-05-20 2020-10-14 パナソニックIpマネジメント株式会社 室内空調システム
IT202000005542A1 (it) 2020-03-16 2021-09-16 Themis S R L Metodo cosmetico per il trattamento della pelle e per la ricrescita dei capelli

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185095A (en) * 1977-11-23 1980-01-22 The Massachusetts General Hospital Nerve growth factor
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator

Also Published As

Publication number Publication date
EP0121338A1 (en) 1984-10-10
ZA841597B (en) 1984-10-31
DK98884D0 (da) 1984-02-24
DE3479321D1 (en) 1989-09-14
JPS6084299A (ja) 1985-05-13
ES8600783A1 (es) 1985-11-01
ATE45382T1 (de) 1989-08-15
EP0121338B1 (en) 1989-08-09
NZ207337A (en) 1987-11-27
JPH067169A (ja) 1994-01-18
KR840008026A (ko) 1984-12-12
JPH05310792A (ja) 1993-11-22
JPH0536031B2 (es) 1993-05-28
IE57013B1 (en) 1992-03-11
DK161152B (da) 1991-06-03
JP2898494B2 (ja) 1999-06-02
JPH0690764A (ja) 1994-04-05
JP2740417B2 (ja) 1998-04-15
EP0121338B2 (en) 1999-10-27
DK98884A (da) 1984-10-04
DK161152C (da) 1991-11-11
IE840493L (en) 1984-09-03
AU574350B2 (en) 1988-07-07
CA1220736A (en) 1987-04-21
AU2525284A (en) 1984-09-06

Similar Documents

Publication Publication Date Title
ES530202A0 (es) Procedimiento para la preparacion de la hormona polipeptidica factor de crecimiento de nervios de humano.
ES531896A0 (es) Procedimiento para producir hormona de crecimiento de humano
PH22461A (en) Preparation of functional human urokinase protein
YU57885A (en) Process for obtaining new human physiologically active polypeptide
WO1988009780A3 (en) Polypeptide compounds having growth hormone releasing activity
ATE113607T1 (de) Polypeptidverbindungen mit wachstumshormonfreisetzender aktivität.
FI861673L (fi) Menetelmä uusien ihmisen kudosplasminogeeniaktivaattorimutanttien valmistamiseksi
ATE122357T1 (de) Polypeptide mit hormonwachstumsbefreiender wirkung.
FI864654L (fi) Menetelmä modifioidun ihmisen t-PA-proteiinin valmistamiseksi
AU2092983A (en) Porcine growth hormone produced by recombinant dna technology
NO852568L (no) Fiskeveksthormon-polypeptid.
HUT43111A (en) Process for producing human lizozime
ES541663A0 (es) Procedimiento para preparar l-carnitina
IT8721616A0 (it) Procedimento per la preparazione dell'ormone della crescita umano
BR8306027A (pt) Composto;composicao e metodo apropriado para o controle do crescimento de vegetacao indesejada
RO92012A (ro) Procedeu pentru prepararea unor complecsi de incluziune
DE3575732D1 (de) Verwendung von gonadoliberin und gonadoliberinagonisten zur herstellung einer pharmazeutischen zubereitung.
IT8567469A0 (it) Procedimento per la preparazionedi n benzilossicarbonil amminoacidi contenenti funzionalita addizionali
ES544961A0 (es) Procedimiento de preparacion de acidos dihidro-5,6-4h-ciclo-penta(b)tiofencarboxilicos-6
ES545512A0 (es) Procedimiento para la preparacion de acidos arilalcanoicos
ES2021085B3 (es) Procedimiento de preparacion de diesteres de acido hexenodioico.
IT8621988A0 (it) Procedimento per la preparazione dell'acido 5-aminoorotico.
ES542555A0 (es) Un procedimiento para preparar acidos (6,11-dihidro-11-oxo- dibenz(b,e,)oxepinil)pentanoicos
DK489086D0 (da) Tetradecapeptider med mitogen aktivitet og fremgangsmaade til stimulering af vaeksten af macrophag-lignende celler
IT1216800B (it) Procedimento per la preparazione della tizanidina

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050712